No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S N/A · No P/S — trailing revenue unavailable or non-positive.
Chart series for revenue are being prepared.
No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S N/A · No P/S — trailing revenue unavailable or non-positive.
Chart series for revenue are being prepared.
The latest delayed quote for Electra Therapeutics Inc. (ETRA) stock was $9.74 as of Oct 5, 2026, 4:00 PM EDT, down 6.08% from the previous close.
Electra Therapeutics, Inc. is a clinical stage biotechnology company.
Medical - Pharmaceuticals · South San Francisco, CA
LATEST PRICE
$9.74
52-WEEK RANGE
$9.28 - $15.50
BETA
0.00
% FROM 52W HIGH
-37.16%
MARKET CAP
$206.61M
DIVIDEND YIELD
Never paid
N/A
PE RATIO
trailing TTM
N/A
PE RATIO (FWD)
forward FY estimate
N/A
P/B RATIO
N/A
P/S RATIO
TTM
N/A
P/OCF RATIO
TTM
N/A
EV/EBITDA
TTM
N/A
DEBT / EQUITY
N/A
REVENUE TTM
N/A
GROSS MARGIN TTM
N/A
NET PROFIT MARGIN TTM
N/A
REVENUE GROWTH TTM
TTM vs prior TTM
N/A
REVENUE CAGR 3Y
N/A
REVENUE CAGR 5Y
N/A
TTM TOTAL RETURN
N/A
3Y TOTAL RETURN
annualized (CAGR)
N/A
5Y TOTAL RETURN
annualized (CAGR)
N/A
Next Earnings Date
N/A
EPS Estimate
N/A
Revenue Est.
N/A
Last Quarter Results
EPS
N/A
vs Estimate
N/A
Revenue
N/A
vs Estimate
N/A
Consensus Rating
No analyst recommendations available
Average Price Target
N/A
Low
N/A
Current
$9.74
High
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1ETRA | $206.61M | $9.74 | -6.08% | N/A | N/A | N/A | N/A |
| 2ANTX | $202.05M | $5.61 | -1.75% | +328.54% | N/A | N/A | vs ETRA |
| 3CGEN | $218.42M | $2.31 | +0.00% | +41.48% | -18.39% | -9.42% | vs ETRA |
| 4ELDN | $192.97M | $2.50 | +0.40% | -11.92% | -15.17% | -37.18% | vs ETRA |
| 5ALEC | $220.94M | $1.99 | +9.94% | -39.91% | -39.17% | N/A | vs ETRA |
| 6KROS | $228.41M | $11.52 | +1.41% | -27.62% | -21.98% | N/A | vs ETRA |
N/A